H.C. Wainwright maintains buy on Akero stock
H.C. Wainwright reaffirmed its Buy rating and $50.00 price target for Akero Therapeutics (NASDAQ:AKRO), representing ...
Hosted on MSN9m
Should You Buy or Hold Discover Financial Stock Before Q4 Earnings?
Discover Financial Services DFS is scheduled to release fourth-quarter 2024 results on Jan. 22, after the closing bell. The ...